Text Only
Search

 
Avian Flu Vaccine 100 Percent Effective in Pittsburgh Animal Tests


27 February 2006
Skirble Report - Download MP3 - Download (MP3) audio clip
Skirble Report - Download MP3 - Listen (MP3) audio clip
Skirble Report - Download RealAudio - Download (Real) audio clip
Skirble Report - Download RealAudio - Listen (Real) audio clip

Researchers at the University of Pittsburgh have genetically engineered an avian flu vaccine from components of the deadly H5N1 virus.  The Journal of Virology reports that the new vaccine completely protected all mice and chickens immunized against the disease. 

The vaccine combines a live virus that causes the common cold with genetic material from the H5N1 virus and is grown in cells.  This differs from the conventional procedure that uses a dead virus cultured in eggs. 

Dr. Andrea Gambotto, avian flu researcher at the University of Pittsburgh in his laboratory
Dr. Andrea Gambotto, avian flu researcher in his laboratory
Dr. Andrea Gambotto of the University of Pittsburgh Medical School is lead author of the study.  He says the new vaccine offers potentially broader protection than one targeted at a specific flu strain.

"If the virus changes a little bit while you are stockpiling it, you may have to start from scratch to develop another vaccine and maybe you have used up the eggs that culture the vaccine.  You may end up with nothing or be incapable of producing a new one," he says.

The study finds that one form of the recombinant virus creates several types of immunity against the H5N1 virus, making it an attractive candidate to prevent the spread of the disease in poultry and perhaps among humans.  Dr. Gambotto says if a pandemic hit, a strain-specific vaccine could be developed within a month.  "The vaccine can still change a little bit," he says.  "We still think that the vaccine will cover those type of changes."   

Dr. Gambotto expects to begin human clinical trials of the vaccine within six months.  He says the genetic engineering approach offers great promise not just against the H5N1 virus, but against other emerging diseases.  

Dr. Gambotto is optimistic that the vaccine will be effective in humans.  'The only thing that I don't know is how much vaccine I need to give to the people to generate immunity which relates to protection," he says

An estimated 150 to 200 million birds have either died in outbreaks or been killed in an effort to prevent the infection from spreading.  170 people have caught avian flu from infected poultry, and half of them have died.  The virus must first mutate in humans before it can be passed from person to person.

emailme.gif E-mail This Article
printerfriendly.gif Print Version

  Related Stories
Bird Flu Computer Database Helps Scientists Develop a Vaccine
US Health Officials Stress Global Cooperation to Combat Bird Flu
 
  Top Story
Serial Explosions Hit Southern Indian City  Audio Clip Available

  More Stories
US Warns Iran Time Running Out for Nuclear Deal  Audio Clip Available
French President, Barack Obama Meet in Paris
Lawyers for Karadzic to Appeal Extradition to The Hague
US Expands Sanctions Against 'Illegitimate' Zimbabwe Government  Audio Clip Available
Rice Urges Pakistan to Clamp Down on Militants Along Border  Audio Clip Available
Cyprus' Rival Leaders Agree to Start Historic Reunification Talks  Audio Clip Available
North Korean Silence Creates Gaps in Tourist Killing Probe  Audio Clip Available
Indian Government Expected to Revive Economic Reform After Confidence Vote  Audio Clip Available
Scientists Solve Mystery of Brilliant Northern, Southern Lights  Audio Clip Available